Abstract
This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, researcher and clinician Patricia M. LoRusso, DO, keeps her focus on patients as she conducts work in early‐phase trials that has led to the approval of several anticancer agents. In addition, the Food and Drug Administration has approved a niraparib and abiraterone acetate combination treatment for advanced prostate cancer, and researchers have identified two new subtypes of human papillomavirus‐related head and neck cancers.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have